Last reviewed · How we verify

Depoestradiol — Competitive Intelligence Brief

Depoestradiol (ESTRADIOL CYPIONATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Estrogen. Area: Oncology.

marketed Estrogen Estrogen receptor beta Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Depoestradiol (ESTRADIOL CYPIONATE) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Depoestradiol TARGET ESTRADIOL CYPIONATE Pfizer marketed Estrogen Estrogen receptor beta 1979-01-01
Osphena OSPEMIFENE Duchesnay marketed Estrogen Agonist/Antagonist [EPC] Estrogen receptor beta 2013-01-01
Clorotrisin CHLOROTRIANISENE marketed chlorotrianisene Estrogen receptor, Estrogen receptor beta 1982-01-01
Demethylchlortetracycline DEMECLOCYCLINE Pfizer marketed Tetracycline-class Antimicrobial Estrogen receptor beta 1960-01-01
Conjugated equine estrogen topical cream Conjugated equine estrogen topical cream University of Louisville marketed Topical hormone replacement therapy; estrogen Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)
Transdermal strogen Transdermal strogen Parc de Salut Mar marketed Hormone replacement therapy (HRT) / Estrogen replacement Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)
Estriol Cream 0.1% Estriol Cream 0.1% Dr. August Wolff GmbH & Co. KG Arzneimittel marketed Estrogen receptor agonist Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Estrogen class)

  1. · 7 drugs in this class
  2. Pfizer · 2 drugs in this class
  3. Mayne Pharma · 1 drug in this class
  4. Pfizer Inc. · 1 drug in this class
  5. Ph Health · 1 drug in this class
  6. Merck & Co. · 1 drug in this class
  7. Apil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Depoestradiol — Competitive Intelligence Brief. https://druglandscape.com/ci/estradiol-cypionate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: